Pharmacokinetics of nelfinavir in HIV‐1‐infected pregnant and nonpregnant women

Abstract

Our results indicate that women in the later stages of pregnancy may be exposed to subtherapeutic concentrations of NFV. Thus, adjustments in drug dosage or frequency of administration may be required.